ZANNES MARIA (President, CEO) received a stock award from BIOAFFINITY TECHNOLOGIES, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/2/2024ACC: 0001493152-24-004766
DirectorOfficer· President, CEO
Since Aug 2022
+23.89K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
23.89K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+23.89K
Price / share
—
Trade value
—
% of position
17.0%
1/31/2024
140.77K→164.66K
Total
Net shares
+23.89K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/31/2024 | A · Award | +23.89K | — | — | 17.0% | 140.77K | 164.66K |
| Total | +23.89K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported